DxS offer a range of genetic analysis services to enable the delivery of safe effective medicines. The services provide support for drug development and are specifically designed to meet the needs of pharmaceutical companies and clinical research organisations. There is an increasing demand from the industry for genetic analysis of clinical trial populations to help understand the individual variation in drug pharmacokinetics and pharmacodynamics.

The genetic analysis services offered by DxS fall into three general categories:

• Clinical Genotyping
• Tumour Mutation Analysis
• DNA Extraction